IE
MYGN icon

Israel Englander’s Myriad Genetics MYGN Stock Holding History

Israel Englander’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,000
Closed -$710K – 6178
2025
Q1 		$710K Sell
80,000
-190,000
-70% -$2.28M ﹤0.01% 4598
2024
Q4 		$3.7M Buy
+270,000
New +$4.98M ﹤0.01% 3103
2024
Q3 		– Sell
-30,000
Closed -$734K – 6341
2024
Q2 		$734K Sell
30,000
-190,000
-86% -$4.17M ﹤0.01% 4336
2024
Q1 		$4.69M Buy
220,000
+120,000
+120% +$2.58M ﹤0.01% 2924
2023
Q4 		$1.91M Sell
100,000
-143,900
-59% -$2.49M ﹤0.01% 3648
2023
Q3 		$3.91M Buy
+243,900
New +$4.64M ﹤0.01% 2940
2023
Q2 		– Sell
-20,400
Closed -$474K – 6495
2023
Q1 		$474K Buy
+20,400
New +$414K ﹤0.01% 4642
2022
Q4 		– Sell
-20,300
Closed -$387K – 6872
2022
Q3 		$387K Sell
20,300
-121,500
-86% -$2.79M ﹤0.01% 5175
2022
Q2 		$2.58M Sell
141,800
-8,200
-5% -$170K ﹤0.01% 3442
2022
Q1 		$3.78M Sell
150,000
-95,000
-39% -$2.43M ﹤0.01% 3233
2021
Q4 		$6.76M Buy
+245,000
New +$7.1M ﹤0.01% 2587
2017
Q3 		– Sell
-150,000
Closed -$3.88M – 3736
2017
Q2 		$3.88M Buy
+150,000
New +$3.18M 0.01% 1677
2017
Q1 		– Sell
-150,000
Closed -$2.5M – 3722
2016
Q4 		$2.5M Buy
+150,000
New +$2.71M 0.01% 1754
2014
Q1 		– Sell
-58,800
Closed -$1.23M – 3743
2013
Q4 		$1.23M Sell
58,800
-68,000
-54% -$1.72M ﹤0.01% 2145
2013
Q3 		$2.98M Buy
+126,800
New +$3.6M 0.01% 1443

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's MYGN Position: Q2 2026 in Review

Israel Englander reduced its Myriad Genetics (MYGN) stake by 0.73% in Q2 2026, selling an estimated $220K and leaving 6,620,372 shares worth $37.8M. The position accounts for 0.01% of the portfolio, ranked #1080.

Israel Englander first reported a position in MYGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $142M in Q3 2024. 195 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Israel Englander held 6,620,372 shares of Myriad Genetics worth $37.8M as of Q2 2026.
  • Israel Englander sold 48,445 Myriad Genetics shares in Q2 2026, an estimated $220K.
  • Myriad Genetics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1080 holding.
  • Israel Englander first reported a position in Myriad Genetics in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Myriad Genetics position peaked at $142M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.